These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 21927405)
1. Dst in the course of post stroke depression. Agarwal A; Nag D; Kar AM; Agarwal AK; Choudhury SR Indian J Psychiatry; 1989 Oct; 31(4):301-4. PubMed ID: 21927405 [TBL] [Abstract][Full Text] [Related]
2. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression. Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277 [TBL] [Abstract][Full Text] [Related]
3. The dexamethasone suppression test. An indicator of depression in stroke but not a predictor of rehabilitation outcome. Reding M; Orto L; Willensky P; Fortuna I; Day N; Steiner SF; Gehr L; McDowell F Arch Neurol; 1985 Mar; 42(3):209-12. PubMed ID: 3977650 [TBL] [Abstract][Full Text] [Related]
4. Dexamethasone suppression test and onset of poststroke depression in patients with ischemic infarction. Harney JH; Fulton C; Ross ED; Rush AJ J Clin Psychiatry; 1993 Sep; 54(9):343-8. PubMed ID: 8407853 [TBL] [Abstract][Full Text] [Related]
5. Mood, vegetative disturbance, and dexamethasone suppression test after stroke. Finklestein S; Benowitz LI; Baldessarini RJ; Arana GW; Levine D; Woo E; Bear D; Moya K; Stoll AL Ann Neurol; 1982 Nov; 12(5):463-8. PubMed ID: 6960804 [TBL] [Abstract][Full Text] [Related]
6. Dexamethasone suppression test and TRH test in endogenous depression. Aggernaes H; Kirkegaard C; Krog-Meyer I; Kijne B; Larsen JK; Laursen AL; Lykke-Olesen L; Mikkelsen PL; Rasmussen S; Bjørum N Acta Psychiatr Scand; 1983 Apr; 67(4):258-64. PubMed ID: 6407280 [TBL] [Abstract][Full Text] [Related]
7. A modified dexamethasone suppression test for endogenous depression. Poland RE; Rubin RT; Lane LA; Martin DJ; Rose DE; Lesser IM Psychiatry Res; 1985 Aug; 15(4):293-9. PubMed ID: 3865246 [TBL] [Abstract][Full Text] [Related]
8. The dexamethasone suppression test for diagnosing depression in stroke patients. Harvey SA; Black KJ Ann Clin Psychiatry; 1996 Mar; 8(1):35-9. PubMed ID: 8743648 [TBL] [Abstract][Full Text] [Related]
9. [Influence of depressive history on biological parameters in major depression]. Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P Encephale; 2002; 28(1):51-8. PubMed ID: 11963343 [TBL] [Abstract][Full Text] [Related]
10. [Use of the dexamethasone test in the differential diagnosis of depressive states]. Nuller IuL; Ostroumova MN; Gordon OI Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):547-51. PubMed ID: 3716705 [TBL] [Abstract][Full Text] [Related]
11. The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry. Am J Psychiatry; 1987 Oct; 144(10):1253-62. PubMed ID: 3310667 [TBL] [Abstract][Full Text] [Related]
12. Dexamethasone suppression test and suicide attempts in schizophrenic patients. Płocka-Lewandowska M; Araszkiewicz A; Rybakowski JK Eur Psychiatry; 2001 Nov; 16(7):428-31. PubMed ID: 11728857 [TBL] [Abstract][Full Text] [Related]
13. The dexamethasone suppression test in chronic alcoholics with and without depression and its relationship to their hepatic status. Majumdar SK; Shaw GK; Bridges PK Drug Alcohol Depend; 1988 Jul; 21(3):231-5. PubMed ID: 3168766 [TBL] [Abstract][Full Text] [Related]
14. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients. Arana GW; Wilens TE; Baldessarini RJ Psychoneuroendocrinology; 1985; 10(1):49-60. PubMed ID: 4001277 [TBL] [Abstract][Full Text] [Related]
15. Serial dexamethasone suppression tests in depressed patients treated only with electroconvulsive therapy. Grunhaus L; Zelnik T; Albala AA; Rabin D; Haskett RF; Zis AP; Greden JF J Affect Disord; 1987; 13(3):233-40. PubMed ID: 2960715 [TBL] [Abstract][Full Text] [Related]
16. The dexamethasone suppression test and the diagnosis of depression in adults with severe and profound developmental disabilities. Mudford OC; Barrera FJ; Murray A; Boundy K; Caldwell K; Goldberg B J Intellect Disabil Res; 1995 Aug; 39 ( Pt 4)():275-83. PubMed ID: 7579985 [TBL] [Abstract][Full Text] [Related]
17. Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression. Greden JF; Albala AA; Haskett RF; James NM; Goodman L; Steiner M; Carroll BJ Biol Psychiatry; 1980 Jun; 15(3):449-58. PubMed ID: 7378518 [TBL] [Abstract][Full Text] [Related]
18. How to evaluate a diagnostic marker test. Lessons from the rise and fall of dexamethasone suppression test. Nierenberg AA; Feinstein AR JAMA; 1988 Mar; 259(11):1699-702. PubMed ID: 3278149 [TBL] [Abstract][Full Text] [Related]
19. Acute administration of buspirone increases the escape of hypothalamic-pituitary-adrenal-axis hormones from suppression by dexamethasone in depression. Maes M; Van Gastel A; Meltzer HY; Cosyns P; Blockx P; Desnyder R Psychoneuroendocrinology; 1996 Jan; 21(1):67-81. PubMed ID: 8778905 [TBL] [Abstract][Full Text] [Related]
20. The dexamethasone suppression test: its relationship to diagnoses, severity of depression and response to treatment. Dratcu L; Calil HM Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):99-117. PubMed ID: 2748868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]